You just read:

New analysis shows cardiorenal risk reductions of Jardiance® are consistent in adults with type 2 diabetes, cardiovascular disease and kidney disease without overt proteinuria

News provided by

Eli Lilly and Company

Jun 10, 2019, 13:00 ET